Developmental dysphasia in children: a comparison of the effectiveness of two modes of peptidergic nootropic therapy
Comparison in people · 2020
- What was studied
- 94 children aged 3–4 with developmental dysphasia
- Main finding
- Compares one course, two courses and no medication over two months; reports vocabulary and phrase-use changes.
Active vocabulary at two months · 2.3-fold after one course, 2.8-fold after two courses, and 1.4-fold with no medication · One versus two courses at two months: p = 0.01
Reported findings and study design
Open controlled comparison of 94 children aged 3–4 with developmental dysphasia: one Cortexin course 27, two courses 40, untreated 27. Each course ten days; repeated courses a month apart; follow-up two months. All parents received speech-stimulation advice.
Population or model 94 children aged 3–4 with developmental dysphasia
Dose, route and schedule
One or two 10-day courses of daily intramuscular Cortexin. The two-course group repeated the course one month later. The article specifies 0.5 mg/kg for children under 20 kg and 10 mg for children over 20 kg. This describes the historical study.
Protocol source ↗ · Original Russian journal methods
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Active vocabulary at two months | 2.3-fold after one course, 2.8-fold after two courses, and 1.4-fold with no medication | One versus two courses at two months: p = 0.01 |
| Spoken phrases at two months | 3.6-fold after one course, 4.2-fold after two courses, and 1.5-fold with no medication | |
| Active vocabulary at least doubled | 12/27 (44.4%) after one course, 32/40 (80.0%) after two courses, and 6/27 (22.2%) with no medication | |
| Spoken phrases after one versus two courses | 7.1 ± 1.1 versus 8.4 ± 1.4 at day 60 | p = 0.795 between the two treated groups |
Selected language measures from Table 2
| Measure | Day | One course (n = 27) | Two courses (n = 40) | No medication (n = 27) |
|---|---|---|---|---|
| Active vocabulary, words | 0 | 13.7 ± 1.8 | 14.9 ± 1.7 | 15.4 ± 1.5 |
| Active vocabulary, words | 60 | 31.7 ± 5.6 | 42.4 ± 3.6 | 22.0 ± 2.0 |
| Spoken phrases | 0 | 2.0 ± 0.4 | 2.0 ± 0.7 | 2.1 ± 0.4 |
| Spoken phrases | 60 | 7.1 ± 1.1 | 8.4 ± 1.4 | 3.1 ± 0.5 |
Mean ± standard error as reported. Within-arm changes and between-arm comparisons are separate.
Fold changes compare each group with its own baseline. The later article reports the same 94-child cohort. The open design and caregiver-reported measures limit causal inference. The one-course and control arms match the 2019 report in size and selected baseline and follow-up results. Treat the two reports as likely overlapping and avoid adding their participant counts.
Source for these results ↗ · Reviewed 2026-11-10
Study limitations and source details
Study limitations
- Allocation and masking unclear; overlap with earlier reports needs checking.
- Pediatric clinical findings do not establish enhancement or safety in healthy adults.
Source details
Original Russian article, methods and selected outcome tables checked.
Sources checked
Citation
Zavadenko NN, Davydova LA, Suvorinova NY. Developmental dysphasia in children: a comparison of the effectiveness of two modes of peptidergic nootropic therapy Zh Nevrol Psikhiatr Im S S Korsakova 120(10):38-44. PMID 33244956
Study source ↗ · DOI 10.17116/jnevro202012010138 · Bibliography entry · Link to this summary